Ascendis Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
Employees
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
Employees

ASND Key Statistics

Market cap
13.39B
Market cap13.39B
Price-Earnings ratio
-51.95
Price-Earnings ratio-51.95
Dividend yield
Dividend yield
Average volume
511.58K
Average volume511.58K
High today
High today
Low today
Low today
Open price
$221.88
Open price$221.88
Volume
0.00
Volume0.00
52 Week high
$248.60
52 Week high$248.60
52 Week low
$124.06
52 Week low$124.06

ASND News

Simply Wall St 3d
Assessing Ascendis Pharma Valuation After Strong Multi Year Shareholder Returns

With no single headline event driving attention to Ascendis Pharma (NasdaqGS:ASND) today, the focus for investors leans toward how its recent share performance...

Assessing Ascendis Pharma Valuation After Strong Multi Year Shareholder Returns
Simply Wall St 6d
Is It Time To Reassess Ascendis Pharma After Its 38% One-Year Surge?

Wondering if Ascendis Pharma at around US$228.06 per share still offers value or if the easy gains are behind it? This article focuses squarely on what the curr...

Is It Time To Reassess Ascendis Pharma After Its 38% One-Year Surge?
TipRanks 7d
Ascendis Pharma Posts Positive Phase 2 Results for Once-Weekly TransCon hGH in Turner Syndrome

The latest announcement is out from Ascendis Pharma ( (ASND) ). On March 17, 2026, Ascendis Pharma reported positive Week 52 topline data from its New InsiGHTS...

Analyst ratings

94%

of 18 ratings
Buy
94.4%
Hold
0%
Sell
5.6%

More ASND News

TipRanks 7d
Ascendis Pharma’s TransCon shows efficacy and safety in Turner Syndrome

Ascendis Pharma (ASND) announced positive Week 52 topline results from New InsiGHTS, its Phase 2 randomized, open-label, active-controlled trial in the U.S. inv...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.